+117.4%
COIN vs MRNA
+34.8%
+82.6%
-66.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.7% | +5.4% | -3.7% | +1.1% |
| 7D | -5.1% | -1.1% | -4.0% | -5.0% |
| 30D | +17.6% | +126.1% | -108.5% | -2.3% |
| 3M | +9.2% | +190.0% | -180.8% | -15.5% |
| 6M | -11.8% | +157.2% | -169.0% | -29.9% |
| YTD | -22.5% | +388.2% | -410.7% | -47.0% |
| 1Y | -45.9% | +467.0% | -512.9% | -64.5% |
| 3Y | +117.4% | +36.1% | +81.3% | +78.4% |
| All | +117.4% | +34.8% | +82.6% | +78.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling